DOWNLOAD PDF

Men’s Essential roles in the Management of Sickle Cell Anemia

*Emmanuel Ifeanyi Obeagu1, Getrude Uzoma Obeagu2, Matthew Chibunna Igwe3, Esther Ugo Alum4,5 and Okechukwu Paul-Chima Ugwu5

1Department of Medical Laboratory Science, Kampala International University, Uganda.

2School of Nursing Science, Kampala International University, Uganda.

3Department of Public Health, Kampala International University, Uganda.

4Department of Biochemistry, Ebonyi State University, Abakaliki, Ebonyi State, Nigeria.

5Department of Publication and Extensions, Kampala International University, Uganda.

*Corresponding author: Emmanuel Ifeanyi Obeagu, Department of Medical Laboratory Science, Kampala International University, Uganda, emmanuelobeagu@yahoo.com, ORCID: 0000-0002-4538-0161

ABSTRACT

Sickle cell anemia (SCA) is a hereditary blood disorder characterized by the presence of abnormal hemoglobin, leading to the deformation of red blood cells and subsequent health complications. While much research has focused on the clinical aspects of SCA, this paper aims to shed light on the crucial and multifaceted roles that men play in the comprehensive management of this condition. Men, as integral members of families and communities, contribute significantly to the support systems necessary for effective SCA management. From a biological standpoint, understanding the genetic inheritance of SCA requires an exploration of paternal contributions. Moreover, men are often primary decision-makers in families, influencing choices related to healthcare, treatment modalities, and lifestyle adjustments. This paper discusses the importance of men’s active involvement in genetic counseling, family planning, and fostering a supportive environment for individuals living with SCA. Psychosocially, men play essential roles as emotional anchors and caregivers, providing crucial support to family members coping with the challenges of SCA. This study explores the impact of male involvement on the mental well-being of both patients and their caregivers. Additionally, it investigates the role of men in community awareness programs, challenging stigmas associated with SCA and promoting a more inclusive and understanding society. Economically, the burden of managing SCA can be substantial. Men often serve as primary earners, and their financial contributions are pivotal in ensuring access to quality healthcare, medications, and educational resources for individuals with SCA. In conclusion, this comprehensive perspective highlights the indispensable roles that men play in the management of sickle cell anemia. Recognizing and harnessing these contributions can lead to more effective strategies for addressing the complex challenges associated with SCA, fostering holistic well-being for individuals, families, and communities affected by this genetic disorder.

Keywords: men; essential roles; management; sickle cell anemia

INTRODUCTION

Sickle cell anemia, a hereditary blood disorder, has long been a subject of scientific curiosity and medical concern [1]. Sickle cell anemia, a well-known hemoglobinopathy, is a genetic disorder that affects millions of people worldwide [2-4]. While it primarily affects individuals of African, Mediterranean, Middle Eastern, and South Asian descent, it is a global health concern [5-9]. This publication serves as a comprehensive guide to understanding this complex condition. The discovery of sickle cell anemia dates back to the early 20th century when Dr. James B. Herrick first described the peculiar sickle-shaped red blood cells in a dental student’s blood sample [10]. Subsequent research led to the identification of the genetic underpinnings of the disease, but many mysteries remained to be unraveled [11]. Sickle cell anemia is an autosomal recessive disorder caused by a mutation in the HBB gene, which encodes the beta-globin subunit of hemoglobin. This mutation leads to the production of abnormal hemoglobin known as hemoglobin S (HbS) [12]. In individuals with sickle cell anemia, HbS causes red blood cells to become rigid and take on a characteristic crescent or sickle shape, leading to a range of clinical complications [13]. Sickle cell anemia is characterized by a wide array of clinical manifestations, including vaso-occlusive crises, anemia, hemolysis, and a susceptibility to infections [14]. Painful episodes, known as sickle cell crises, are a hallmark of the condition and can be excruciating. These complications are the result of the abnormal red blood cells becoming lodged in blood vessels, obstructing blood flow [15]. The diagnosis of sickle cell anemia is typically made through blood tests, including hemoglobin electrophoresis and genetic testing to confirm the presence of HbS. Prenatal and neonatal screening have become standard in many regions to identify affected infants early [16]. While there is no cure for sickle cell anemia, management and treatment options have improved significantly over the years [17]. These include pain management, blood transfusions, hydroxyurea therapy, and stem cell transplantation, which offers the possibility of a cure. Comprehensive care by a multi-disciplinary medical team is essential for improving the quality of life of individuals with sickle cell anemia [18]. Individuals with sickle cell anemia face numerous challenges, including a risk of stroke, organ damage, and a reduced life expectancy [19]. However, ongoing research and advances in gene therapy hold promise for more effective treatments and even potential cures. Clinical trials, genetic therapies, and better understanding of the disease’s pathophysiology are actively pursued. Sickle cell anemia is a complex genetic disorder with a rich history of discovery and ongoing research. This publication provides a foundational understanding of the condition, from its genetic basis to clinical manifestations, diagnostic approaches, and management. The pursuit of improved treatments and potential cures continues to offer hope for those affected by this challenging disease [20]. Historically, the management of sickle cell anemia has often been perceived as predominantly a women’s responsibility, closely linked to maternal and childcare roles [21]. However, as our understanding of the disease deepens and our approach to healthcare continues to evolve, it is increasingly apparent that men have a vital role to play in the comprehensive management of sickle cell anemia. The holistic management of this complex condition involves not only the affected individuals themselves but also their families and communities. This publication seeks to shed light on the crucial role that men can and do play in supporting, caring for, advocating on behalf of, and advancing research in the field of sickle cell anemia. Through this comprehensive exploration, we aim to shift the paradigm and emphasize the importance of men’s involvement in addressing the challenges posed by this condition.

Caregiving and Support

Sickle cell anemia is a genetic blood disorder that affects millions of individuals worldwide, particularly those of African, Mediterranean, or Middle Eastern descent [22]. While significant progress has been made in the medical management of the disease, it is essential to recognize the crucial and often underestimated role that men play in the holistic care and support of individuals living with sickle cell anemia [22]. In many cases, the responsibilities extend beyond being a caregiver; men provide emotional, practical, and moral support that is invaluable to the well-being and quality of life of those affected by this chronic condition. The emotional well-being of individuals with sickle cell anemia is deeply intertwined with their ability to manage the physical and psychological challenges of the condition. Men, as partners, family members, and friends, are often the first line of defense in providing this vital emotional support [24]. Living with sickle cell anemia can be emotionally draining, as patients contend with pain crises, hospitalizations, and the uncertainty that comes with chronic illness. Men’s empathetic presence, a compassionate ear, and unwavering encouragement are indispensable during these difficult moments. Their ability to provide emotional support can significantly alleviate the mental burden and enhance the resilience of individuals with sickle cell anemia [25]. Beyond emotional support, men offer critical practical assistance that contributes to a better quality of life for those with sickle cell anemia. Individuals with sickle cell anemia frequently require transportation to medical appointments and emergency room visits. Men’s involvement in driving and ensuring timely healthcare access is invaluable [26]. Consistency in medication adherence is crucial for managing sickle cell anemia and preventing complications. Men can play a pivotal role in organizing and overseeing medication regimens, thereby ensuring their loved ones receive the necessary treatment [27]. During pain crises or episodes of illness, individuals with sickle cell anemia may struggle with basic tasks such as meal preparation, bathing, and mobility. Men can step in to assist with these ADLs, promoting comfort and preserving their loved one’s dignity [28]. For parents with sickle cell anemia, men’s involvement in childcare can be essential during periods of illness or pain crises, allowing individuals to focus on self-care and recovery [29]. Men can provide support by accompanying individuals with sickle cell anemia to medical appointments. This presence ensures that important information is accurately relayed to healthcare providers and that individuals feel more secure in discussing treatment options and health concerns. It fosters a sense of partnership in the healthcare journey and reduces feelings of isolation [30]. Understanding sickle cell anemia, its management, and potential complications is paramount for those involved in the care of individuals with the condition [31]. Men can actively participate in educating themselves about the disease, advocating for appropriate treatment, and raising awareness in their communities. Through their commitment to education and advocacy, they empower individuals with sickle cell anemia and help reduce the stigma associated with the condition [32].

Top of Form

Bottom of Form

Top of Form

Bottom of Form

The Impact of Men’s Involvement in the Management of Sickle Cell Anemia

Sickle cell anemia, a genetically inherited blood disorder, has historically been perceived as a predominantly female concern, largely associated with maternal roles, childcare, and family caregiving [33]. However, as our understanding of the disease has evolved, so too has the recognition of the pivotal role that men can play in its comprehensive management. Men’s involvement in the care and support of individuals with sickle cell anemia has a profound impact, not only on the individuals themselves but on families, communities, and healthcare systems as a whole [34]. Men’s involvement in the management of sickle cell anemia leads to an enhanced quality of life for individuals living with the condition [35]. Emotional support, practical assistance, and a caring presence during pain crises contribute to reduced stress, anxiety, and feelings of isolation. When individuals with sickle cell anemia feel emotionally supported and have their practical needs met, their overall well-being is significantly improved [36]. Treatment adherence is a critical aspect of managing sickle cell anemia. It involves strict adherence to medication regimens, dietary modifications, and consistent medical follow-up. Men’s involvement can play a substantial role in ensuring that individuals adhere to these treatment plans. Men can help to remind patients to take their medications, accompany them to medical appointments, and monitor their health, ultimately reducing the risk of complications and hospitalizations [37]. Stigmatization of individuals with sickle cell anemia is a pervasive issue, driven in part by a lack of awareness and understanding. Men’s involvement in advocacy and education can help combat this stigma. By openly discussing the condition, advocating for the needs of those affected, and participating in awareness campaigns, men can contribute to reducing the misconceptions and prejudices associated with sickle cell anemia [38]. Men who actively accompany individuals with sickle cell anemia to medical appointments can facilitate better communication between patients and healthcare providers. This support ensures that critical medical information is shared, questions are addressed, and treatment plans are clearly understood. Improved communication leads to better healthcare outcomes and more informed decision-making [39]. Men’s involvement in the management of sickle cell anemia does not only impact those with the condition but also extends to caregivers. Caregivers, often women, experience stress and emotional strain when providing support to their loved ones. Men’s participation in caregiving and support can alleviate some of this burden, ensuring that caregivers do not become overwhelmed or burnt out [40]. Men with sickle cell anemia can actively participate in clinical trials and research initiatives. Their involvement is critical to advancing our understanding of the disease, its treatment, and potential therapies. By participating in research, men can contribute to the development of innovative treatments that have the potential to improve the lives of individuals with sickle cell anemia in the future [41]. Men’s involvement in the management of sickle cell anemia fosters a culture of empathy and support within families and communities. This cultural shift can lead to a broader societal change, reducing the stigma surrounding the condition and fostering a more inclusive and supportive environment for those affected by it [42]. The impact of men’s involvement in the management of sickle cell anemia is multifaceted and far-reaching. It positively affects the lives of individuals with the condition, their caregivers, and their communities. By recognizing the importance of men’s roles in holistic care and actively engaging them in the care and support of those with sickle cell anemia, we can create a more compassionate and informed approach to managing this complex and challenging disease [43].

The Importance of Research and Men’s Involvement in the Management of Sickle Cell Anemia

Sickle cell anemia is a complex, inherited blood disorder that affects millions of people worldwide. It not only imposes a significant burden on individuals and their families but also poses substantial challenges to healthcare systems. To advance our understanding of the disease, improve treatments, and ultimately find a cure, active participation in research is crucial. Men, in particular, play a vital role in furthering the field of sickle cell anemia research [44]. One of the most direct ways in which men can contribute to the advancement of sickle cell anemia research is by participating in clinical trials. Clinical trials are essential for testing the safety and efficacy of new treatments, therapies, and interventions. By enrolling in these trials, individuals with sickle cell anemia, including men, provide valuable data and insights that can lead to the development of more effective and targeted therapies [45]. While active participation in clinical trials is critical, supporting research initiatives in other ways is equally important. Men can contribute to research by raising awareness about the condition, participating in fundraising efforts, and advocating for increased research funding. Financial support for research organizations and initiatives can be a powerful driver in facilitating groundbreaking discoveries and advancements in the field [46]. Men can play a key role in raising awareness about sickle cell anemia, not only to encourage greater support for research but also to reduce the stigma and misconceptions surrounding the condition. By sharing personal stories, engaging in educational activities, and participating in public outreach, men can help educate their communities and dispel myths about the disease. This, in turn, can lead to more widespread understanding and support for research efforts [47]. Men with sickle cell anemia, or those who are carriers of the sickle cell trait, can encourage their family members and partners to seek genetic counseling. This counseling helps individuals understand their genetic risk and make informed decisions about family planning. By doing so, men can contribute to reducing the prevalence of the disease in future generations [48]. Research that includes a diverse range of participants is more likely to yield results that are applicable to all individuals with sickle cell anemia. Men can advocate for inclusivity in clinical trials and research studies, ensuring that all affected populations have an opportunity to contribute to the advancement of the field [49]. Men can actively participate in patient-centered research initiatives that prioritize the needs and perspectives of individuals living with sickle cell anemia. These efforts often lead to the development of more patient-friendly treatments, a better understanding of the disease’s impact on daily life, and improved strategies for care and management [50]. The importance of research in the management of sickle cell anemia cannot be overstated. Men’s involvement is central to advancing our knowledge of the disease, developing more effective treatments, and ultimately finding a cure. Through participation in clinical trials, raising awareness, supporting research, advocating for genetic counseling, and encouraging inclusivity and diversity in research, men can contribute significantly to the collective effort to combat this challenging condition. Their active involvement can change the landscape of sickle cell anemia management and improve the lives of those affected by it [51]. While men play an essential role in the management of sickle cell anemia, their involvement is not without its challenges. These challenges stem from societal perceptions, traditional gender roles, and the unique dynamics associated with a chronic and often painful condition like sickle cell anemia. Understanding and addressing these challenges is vital to ensuring effective and inclusive care for individuals living with this disease [52]. Societal expectations regarding gender roles can present a significant challenge. Men are often expected to be strong, stoic, and less expressive of their emotions. This can hinder their ability to provide emotional support to individuals with sickle cell anemia who may need to discuss their pain, fear, or anxiety. Breaking free from these gender expectations is necessary to provide the holistic support required [53]. Men may lack comprehensive knowledge about sickle cell anemia, its symptoms, and its management. This lack of education can hinder their ability to provide effective support and assistance. Ensuring that men are well-informed about the condition is crucial for them to actively engage in the care of their loved ones [54]. Men, like women, often face the challenge of balancing work and caregiving responsibilities. Sickle cell anemia can be unpredictable, with pain crises and hospitalizations requiring immediate attention. Men may find it difficult to manage these responsibilities alongside their professional commitments, which can lead to stress and exhaustion [55]. Men who actively support individuals with the disease may face stigmatization themselves. This can manifest in derogatory comments, discrimination, or insensitivity from friends, family, or colleagues, which can be emotionally taxing [56]. The costs associated with managing sickle cell anemia, such as medication, medical appointments, and hospitalizations, can be substantial. Men may find it challenging to navigate the financial burden of the condition, which can be exacerbated if they need to reduce working hours or take time off to provide care and support [57]. Providing long-term care for a loved one with sickle cell anemia can lead to caregiver burnout. Men who take on caregiving roles may face this risk, as the emotional and physical demands of providing care, combined with their own life responsibilities, can be overwhelming [58]. Men may prioritize the health and well-being of their loved ones above their own. This selflessness can lead to neglect of their own physical and emotional needs, potentially resulting in their own health challenges and emotional exhaustion [59]. Cultural and societal norms can further complicate men’s involvement in sickle cell anemia management. In some cultures, discussing health issues openly may be considered taboo, making it challenging to address the emotional and psychological aspects of the disease [60]. Men may find it challenging to locate and engage with support networks specifically tailored to caregivers and families of individuals with sickle cell anemia. These support networks can provide valuable resources and emotional support [61]. In addressing these challenges, it is essential to promote awareness, education, and support networks that recognize and address the unique issues faced by men in the management of sickle cell anemia. Encouraging open dialogue, providing resources, and fostering a more inclusive approach to caregiving and support can help men overcome these challenges and contribute effectively to the holistic care of individuals with sickle cell anemia [62].Top of FormBottom of Form

Ways to Improve Men’s Involvement in the Management of Sickle Cell Anemia

Enhancing men’s involvement in the management of sickle cell anemia is critical for comprehensive care. It requires addressing various factors, including societal expectations, awareness, education, and support networks. Here are some ways to improve men’s involvement in the management of this challenging condition [63]. Promote educational programs that provide information about sickle cell anemia, its symptoms, treatment options, and the challenges individuals face. Encourage healthcare providers to offer comprehensive education not only to patients but also to their families, including men. Develop and distribute informational materials tailored to men, addressing their specific questions and concerns.  Launch public awareness campaigns to combat the stigmatization of sickle cell anemia. Emphasize the importance of empathy, understanding, and support. Encourage open conversations about the condition within families, communities, and workplaces to reduce the stigma associated with it [63-66].  Establish support groups and networks for caregivers, partners, and families of individuals with sickle cell anemia. These networks can offer emotional support and information sharing. Engage men in these support groups, ensuring that they have a platform to discuss their experiences and challenges [67-73]. Provide training for healthcare professionals to be sensitive to the unique challenges that men may face when caring for individuals with sickle cell anemia. Encourage healthcare providers to involve men in care discussions, making them feel valued and included in the decision-making process [74-79]. Foster an environment of gender neutrality in healthcare settings to ensure that men feel comfortable discussing emotional and caregiving concerns. Ensure that healthcare providers address the needs of both male and female caregivers and support their well-being [80-85]. Encourage workplace policies that support a balance between work and caregiving responsibilities. Flexible hours, remote work options, and paid leave can help men fulfill their caregiving roles without compromising their professional responsibilities [86-93]. Engage men in advocacy efforts to raise awareness about sickle cell anemia, secure funding for research, and advocate for better healthcare policies. Encourage men to participate in events, campaigns, and initiatives aimed at reducing the impact of the disease and promoting inclusivity [94-99]. Promote the use of inclusive language in medical literature, public health campaigns, and educational materials. Address caregivers as a group that includes both men and women. Ensure that resources do not perpetuate stereotypes that may discourage men from actively participating in caregiving [100-102]. Encourage men to seek support for their own emotional well-being and to reach out to healthcare professionals if they are struggling with the emotional challenges of caregiving. Highlight the importance of self-care and stress management for men involved in the management of sickle cell anemia [89-92]. Promote research on the specific needs, experiences, and challenges of men involved in the care of individuals with sickle cell anemia [70]. Collect and analyze data on the effectiveness of interventions aimed at improving men’s involvement in the management of the disease [93-102].

CONCLUSION

Improving men’s involvement in the management of sickle cell anemia requires a multi-faceted approach that encompasses awareness, education, support networks, and advocacy. By addressing these aspects, we can create a more inclusive and informed approach to the care of individuals with this condition, ultimately enhancing their quality of life and well-beingTop of Form.Bottom of Form The involvement of men in the management of sickle cell anemia is a crucial aspect of comprehensive care. Their support, advocacy, education, and participation in research can significantly improve the quality of life for individuals with sickle cell anemia and contribute to advancements in treatment and understanding of the condition. It is essential to recognize and empower men in the sickle cell community, acknowledging their valuable role in holistic care and management.

Acknowledgement

Not applicable

Funding

This paper received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors

Conflict of Interest

The authors declare no conflict of interest in preparing this article

REFERENCES

  1. Egesa WI, Nakalema G, Waibi WM, Turyasiima M, Amuje E, Kiconco G, Odoch S, Kumbakulu PK, Abdirashid S, Asiimwe D. Sickle cell disease in children and adolescents: a review of the historical, clinical, and public health perspective of sub-saharan africa and beyond. International Journal of Pediatrics. 2022;2022.
  2. Mandal AK, Mitra A, Das R. Sickle cell hemoglobin. Vertebrate and Invertebrate Respiratory Proteins, Lipoproteins and other Body Fluid Proteins. 2020:297-322.
  3. Obeagu EI, Ochei KC, Nwachukwu BN, Nchuma BO. Sickle cell anaemia: a review. Scholars Journal of Applied Medical Sciences. 2015;3(6B):2244-52.
  4. Obeagu EI. Erythropoeitin in Sickle Cell Anaemia: A Review. International Journal of Research Studies in Medical and Health Sciences. 2020;5(2):22-8.
  5. Obeagu EI. Sickle Cell Anaemia: Haemolysis and Anemia. Int. J. Curr. Res. Chem. Pharm. Sci. 2018;5(10):20-1.
  6. Kattamis A, Forni GL, Aydinok Y, Viprakasit V. Changing patterns in the epidemiology of β‐ European Journal of Haematology. 2020 Dec;105(6):692-703.
  7. Obeagu EI, Bunu UO, Obeagu GU, Habimana JB. Antioxidants in the Management of Sickle Cell Anaemia: An Area to Be Exploited for the Wellbeing of the Patients. International Research in Medical and Health Sciences. 2023;6(4):12-7.
  8. Obeagu EI, Muhimbura E, Kagenderezo BP, Uwakwe OS, Nakyeyune S, Obeagu GU. An Update on Interferon Gamma and C Reactive Proteins in Sickle Cell Anaemia Crisis. J Biomed Sci. 2022;11(10):84.
  9. Obeagu EI, Dahir FS, Francisca U, Vandu C, Obeagu GU. Hyperthyroidism in sickle cell anaemia. Int. J. Adv. Res. Biol. Sci. 2023;10(3):81-9.
  10. Reid C, Rodgers G. Sickle cell disease: demystifying the beginnings. Renaissance of sickle cell disease research in the genomic era. London, Great Britain: World Scientific. 2007:1-2.
  11. Gao HM, Hong JS. Gene–environment interactions: key to unraveling the mystery of Parkinson’s disease. Progress in neurobiology. 2011;94(1):1-9.
  12. Adekile A. The genetic and clinical significance of fetal hemoglobin expression in sickle cell disease. Medical Principles and Practice. 2021;30(3):201-11.
  13. Faris KS, Alrehaili AF, Alsobhi OR, Alenzi AA, Almuhammadi MM, Alerwi FS, Alsuhaimi OO, Almuzaini MM, Faid HA, Kabli MF. Genetic Blood Disorders in Saudi Arabia. Multi-Knowledge Electronic Comprehensive Journal for Education & Science Publications (MECSJ). 2022;1(58).
  14. Ochocinski D, Dalal M, Black LV, Carr S, Lew J, Sullivan K, Kissoon N. Life-threatening infectious complications in sickle cell disease: a concise narrative review. Frontiers in Pediatrics. 2020; 8:38.
  15. Ballas SK, Gupta K, Adams-Graves P. Sickle cell pain: a critical reappraisal. Blood, The Journal of the American Society of Hematology. 2012 Nov 1;120(18):3647-56.
  16. Arishi WA, Alhadrami HA, Zourob M. Techniques for the detection of sickle cell disease: a review. Micromachines. 2021;12(5):519.
  17. Salinas Cisneros G, Thein SL. Recent advances in the treatment of sickle cell disease. Frontiers in physiology. 2020; 11:435.
  18. Lakkakula BV, Sahoo R, Verma H, Lakkakula S. Pain management issues as part of the comprehensive care of patients with sickle cell disease. Pain Management Nursing. 2018 ;19(6):558-72.
  19. Thein MS, Igbineweka NE, Thein SL. Sickle cell disease in the older adult. Pathology. 2017;49(1):1-9.
  20. Esoh K, Wonkam A. Evolutionary history of sickle-cell mutation: implications for global genetic medicine. Human molecular genetics. 2021;30(R1): R119-28.
  21. Berghs M, Dyson SM, Gabba A, Nyandemo SE, Roberts G, Deen G. “You have to find a caring man, like your father!” gendering sickle cell and refashioning women’s moral boundaries in Sierra Leone. Social Science & Medicine. 2020; 259:113148.
  22. Burton EK. Red crescents: Race, genetics, and sickle cell disease in the middle east. Isis. 2019 ;110(2):250-69.
  23. Poku BA, Caress AL, Kirk S. Adolescents’ experiences of living with sickle cell disease: An integrative narrative review of the literature. International Journal of Nursing Studies. 2018; 80:20-8.
  24. Owoo F, Tadros E. Conceptualizing Sickle Cell Disease and the Family with Intergenerational Family Therapy. The American Journal of Family Therapy. 2022 11:1-9.
  25. Thomas VJ, Taylor LM. The psychosocial experience of people with sickle cell disease and its impact on quality of life: Qualitative findings from focus groups. British journal of health psychology. 2002;7(3):345-63.
  26. Smith SK, Johnston J, Rutherford C, Hollowell R, Tanabe P. Identifying social-behavioral health needs of adults with sickle cell disease in the emergency department. Journal of Emergency Nursing. 2017;43(5):444-50.
  27. Walsh KE, Cutrona SL, Kavanagh PL, Crosby LE, Malone C, Lobner K, Bundy DG. Medication adherence among pediatric patients with sickle cell disease: a systematic review. Pediatrics. 2014;134(6):1175-83.
  28. Andersson M, Hallberg IR, Edberg AK. Old people receiving municipal care, their experiences of what constitutes a good life in the last phase of life: A qualitative study. International journal of nursing studies. 2008;45(6):818-28.
  29. Al Nagshabandi EA, Abdulmutalib IA. Self-care management and self-efficacy among adult patients with sickle cell disease. American Journal of Nursing Research. 2019;7(1):51-7.
  30. Cordeiro RC, Ferreira SL, Santos AC. The illness of women and men with sickle cell disease: a Grounded Theory study. Revista latino-americana de enfermagem. 2015; 23:1113-20.
  31. Tanabe P, Spratling R, Smith D, Grissom P, Hulihan M. Understanding the complications of sickle cell disease. The American journal of nursing. 2019;119(6):26.
  32. Williams AM, Smith-Whitley K. Sickle Cell Disease, 2015: A Patient Advocate’s Perspective. American Journal of Preventive Medicine. 2016;51(1): S5-9.
  33. Iliyasu Z, Borodo AM, Jibir BW, Nass NS, Aliyu MH. “A child with sickle cell disease can’t live with just anyone.” A mixed methods study of socio‐behavioral influences and severity of sickle cell disease in northern Nigeria. Health Science Reports. 2021;4(1): e222.
  34. Thomas VJ, Taylor LM. The psychosocial experience of people with sickle cell disease and its impact on quality of life: Qualitative findings from focus groups. British journal of health psychology. 2002;7(3):345-63.
  35. Mann-Jiles V, Morris DL. Quality of life of adult patients with sickle cell disease. Journal of the American Association of Nurse Practitioners. 2009;21(6):340-9.
  36. Dovern E, Nijland SJ, van Muilekom MM, Suijk LM, Hoogendoorn GM, Mekelenkamp H, Biemond BJ, Haverman L, Nur E. Physical, Mental, and Social Health of Adult Patients with Sickle Cell Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Mixed-Methods Study. Transplantation and Cellular Therapy. 2023 Apr 1;29(4):283-e1.
  37. Stuart MJ, Nagel RL. Sickle-cell disease. The Lancet. 2004;364(9442):1343-60.
  38. Ciribassi RM, Patil CL. “We don’t wear it on our sleeve”: Sickle cell disease and the (in) visible body in parts. Social Science & Medicine. 2016; 148:131-8.
  39. Jacob E, Pavlish C, Duran J, Stinson J, Lewis MA, Zeltzer L. Facilitating pediatric patient-provider communications using wireless technology in children and adolescents with sickle cell disease. Journal of Pediatric Health Care. 2013;27(4):284-92.
  40. Atkin K, Ahmad WI. Family care‐giving and chronic illness: how parents cope with a child with a sickle cell disorder or thalassaemia. Health & social care in the community. 2000;8(1):57-69.
  41. Lee LH, Whisenton LH, Benger J, Lanzkron S. A community-centered approach to sickle cell disease and clinical trial participation: an evaluation of perceptions, facilitators, and barriers. Blood Advances. 2021;5(23):5323-31.
  42. Foster N, Ellis M. Sickle cell anaemia and the experiences of young people living with the condition. Nursing children and young people. 2023;35(3).
  43. Valrie CR. Daily pain and sleep in children with sickle cell disease: An analysis of daily diaries utilizing multilevel models. The University of North Carolina at Chapel Hill; 2006.
  44. Kaur M, Dangi CB, Singh M. An overview on sickle cell disease profile. Asian J Pharm Clin Res. 2013;6(1):25-37.
  45. Salinas Cisneros G, Thein SL. Recent advances in the treatment of sickle cell disease. Frontiers in physiology. 2020; 11:435.
  46. Mavris M, Le Cam Y. Involvement of patient organisations in research and development of orphan drugs for rare diseases in Europe. Molecular syndromology. 2012;3(5):237-43.
  47. Long KA, Thomas SB, Grubs RE, Gettig EA, Krishnamurti L. Attitudes and beliefs of African-Americans toward genetics, genetic testing, and sickle cell disease education and awareness. Journal of genetic counseling. 2011; 20:572-92.
  48. Faremi AF, Olatubi IM, Lawal YR. Knowledge of sickle cell disease and pre-marital genotype screening among students of a tertiary educational institution in South Western Nigeria. International Journal of Caring Sciences. 2018;11(1):285-95.
  49. Hershberger PE, Gallo AM, Molokie R, Thompson AA, Suarez ML, Yao Y, Wilkie DJ. Perception of young adults with sickle cell disease or sickle cell trait about participation in the CHOICES randomized controlled trial. Journal of Advanced Nursing. 2016;72(6):1430-40.
  50. Mayo-Gamble TL, Murry VM, Cunningham-Erves J, Cronin RM, Lari N, Gorden A, Scott L, DeBaun MR, Thompson T. Engaging individuals with sickle cell disease in patient-centered outcomes research: a community health ambassador training model. Journal of Health Care for the Poor and Underserved. 2020;31(1):353-69.
  51. Elander J, Lusher J, Bevan D, Telfer P, Burton B. Understanding the causes of problematic pain management in sickle cell disease: evidence that pseudoaddiction plays a more important role than genuine analgesic dependence. Journal of pain and symptom management. 2004;27(2):156-69.
  52. Houwing ME, De Pagter PJ, Van Beers EJ, Biemond BJ, Rettenbacher E, Rijneveld AW, Schols EM, Philipsen JN, Tamminga RY, van Draat KF, Nur E. Sickle cell disease: clinical presentation and management of a global health challenge. Blood reviews. 2019; 37:100580.
  53. Táíwò OO. Stoicism (as emotional compression) is emotional labor. Feminist Philosophy Quarterly. 2020;6(2).
  54. Adewoyin AS. Management of sickle cell disease: a review for physician education in Nigeria (sub-saharan Africa). Anemia. 2015.
  55. Benjamin LJ, Swinson GI, Nagel RL. Sickle cell anemia day hospital: an approach for the management of uncomplicated painful crises. Blood, The Journal of the American Society of Hematology. 2000;95(4):1130-6.
  56. Wesley KM, Zhao M, Carroll Y, Porter JS. Caregiver perspectives of stigma associated with sickle cell disease in adolescents. Journal of Pediatric Nursing. 2016;31(1):55-63.
  57. Blinder MA, Vekeman F, Sasane M, Trahey A, Paley C, Duh MS. Age‐related treatment patterns in sickle cell disease patients and the associated sickle cell complications and healthcare costs. Pediatric Blood & Cancer. 2013;60(5):828-35.
  58. Al Saif K, Abdulla FM, Alrahim A, Abduljawad S, Matrook Z, Abdulla JJ, Bughamar F, Alasfoor F, Taqi R, Almarzooq A, Ahmed J. Caregivers’ experience of seeking care for adolescents with sickle cell disease in a tertiary care hospital in Bahrain. Plos one. 2022;17(4): e0266501.
  59. World Health Organization. The health and well-being of men in the WHO European Region: better health through a gender approach. World Health Organization. Regional Office for Europe; 2018.
  60. Marsh VM, Kamuya DM, Molyneux SS. ‘All her children are born that way’: gendered experiences of stigma in families affected by sickle cell disorder in rural Kenya. Ethnicity & health. 2011;16(4-5):343-59.
  61. Phillips S, Chen Y, Masese R, Noisette L, Jordan K, Jacobs S, Hsu LL, Melvin CL, Treadwell M, Shah N, Tanabe P. Perspectives of individuals with sickle cell disease on barriers to care. PloS one. 2022;17(3): e0265342.
  62. Spencer K, Foster P, Whittamore KH, Goldberg SE, Harwood RH. Delivering dementia care differently—evaluating the differences and similarities between a specialist medical and mental health unit and standard acute care wards: a qualitative study of family carers’ perceptions of quality of care. BMJ open. 2013;3(12): e004198.
  63. Okpala I, Thomas V, Westerdale N, Jegede T, Raj K, Daley S, Costello‐Binger H, Mullen J, Rochester‐Peart C, Helps S, Tulloch E. The comprehensive care of sickle cell disease. European Journal of Haematology. 2002;68(3):157-62.
  64. Diniz KK, Pagano AS, Fernandes AP, Reis IA, Pinheiro Júnior LG, Torres HD. Knowledge of professional healthcare providers about sickle cell disease: Impact of a distance education course. Hematology, Transfusion and Cell Therapy. 2019; 41:62-8.
  65. Early ML, Strodel RJ, Lake IV, Ruddy JA, Saba JA, Singh SM, Lanzkron S, Mack JW, Meier ER, Christianson MS, Pecker LH. Acceptable, hopeful, and useful: development and mixed-method evaluation of an educational tool about reproductive options for people with sickle cell disease or trait. Journal of Assisted Reproduction and Genetics. 20221:1-1.
  66. Newsome D. My story, my identity and my relationship with work: sickle cell disorder. Canterbury Christ Church University (United Kingdom); 2016.
  67. Tluway F, Makani J. Sickle cell disease in Africa: an overview of the integrated approach to health, research, education and advocacy in Tanzania, 2004–2016. British journal of haematology. 2017;177(6):919-29.
  68. Houwing ME, Buddenbaum M, Verheul TC, de Pagter AP, Philipsen JN, Hazelzet JA, Cnossen MH. Improving access to healthcare for paediatric sickle cell disease patients: a qualitative study on healthcare professionals’ views. BMC Health Services Research. 2021; 21:1-3.
  69. Jenerette CM, Brewer C. Health-related stigma in young adults with sickle cell disease. Journal of the National Medical Association. 2010;102(11):1050-5.
  70. Glassberg JA, Linton EA, Burson K, Hendershot T, Telfair J, Kanter J, Gordeuk VR, King AA, Melvin CL, Shah N, Hankins JS. Publication of data collection forms from NHLBI funded sickle cell disease implementation consortium (SCDIC) registry. Orphanet journal of rare diseases. 2020; 15:1-6.
  71. Obeagu EI, Muhimbura E, Kagenderezo BP, Uwakwe OS, Nakyeyune S, Obeagu GU. An Update on Interferon Gamma and C Reactive Proteins in Sickle Cell Anaemia Crisis. J Biomed Sci. 2022;11(10):84.
  72. Obeagu EI, Bunu UO, Obeagu GU, Habimana JB. Antioxidants in the Management of Sickle Cell Anaemia: An Area to Be Exploited for the Wellbeing of the Patients. International Research in Medical and Health Sciences. 2023;6(4):12-7.
  73. Obeagu EI. An update on micro RNA in sickle cell disease. Int J Adv Res Biol Sci. 2018; 5:157-8.
  74. Obeagu EI, Ogunnaya FU, Obeagu GU, Ndidi AC. Sickle Cell Anaemia: A Gestational Enigma. Migration. 2023; 17:18.
  75. Obeagu EI, Babar Q. Covid-19 and Sickle Cell Anemia: Susceptibility and Severity. J. Clinical and Laboratory Research. 2021;3(5):2768-0487.
  76. Obeagu EI, Getrude U. Obeagu.,(2023). Evaluation of Hematological Parameters of Sickle Cell Anemia Patients with Osteomyelitis in A Tertiary Hospital in Enugu, Nigeria. Journal of Clinical and Laboratory Research.;6(1):2768-0487.
  77. Obeagu EI, Dahir FS, Francisca U, Vandu C, Obeagu GU. Hyperthyroidism in sickle cell anaemia. Int. J. Adv. Res. Biol. Sci. 2023;10(3):81-9.
  78. Njar VE, Ogunnaya FU, Obeagu EI. Knowledge And Prevalence of The Sickle Cell Trait Among Undergraduate Students Of The University Of Calabar. Prevalence.;5(100):0-5.
  79. Swem CA, Ukaejiofo EO, Obeagu EI, Eluke B. Expression of micro RNA 144 in sickle cell disease. Int. J. Curr. Res. Med. Sci. 2018;4(3):26-32.
  80. Obeagu EI. Depression in Sickle Cell Anemia: An Overlooked Battle. Int. J. Curr. Res. Chem. Pharm. Sci. 2023;10(10):41-4.
  81. Obeagu EI. Sickle cell anaemia: Historical perspective, Pathophysiology and Clinical manifestations. Int. J. Curr. Res. Chem. Pharm. Sci. 2018;5(11):13-5.
  82. Obeagu EI, Obeagu GU. Sickle Cell Anaemia in Pregnancy: A Review. International Research in Medical and Health Sciences. 2023;6(2):10-3.
  83. Edward U, Osuorji VC, Nnodim J, Obeagu EI. Evaluationof Trace Elements in Sickle Cell Anaemia Patients Attending Imo State Specialist Hospital, Owerri. Madonna University journal of Medicine and Health Sciences. 2022;2(1):218-34.
  84. Obeagu EI. Vaso-occlusion and adhesion molecules in sickle cells disease. Int J Curr Res Med Sci. 2018;4(11):33-5.
  85. Ifeanyi OE, Stella EI, Favour AA. Antioxidants in the Management of Sickle Cell Anaemia. Int J Hematol Blood Disord (Internet) 2018 (cited 2021 Mar 4); 3. Available from: https://symbiosisonlinepublishing. com/hematology/hema tology25. php. 2018 Sep.
  86. Nnodim J, Uche U, Ifeoma U, Chidozie N, Ifeanyi O, Oluchi AA. Hepcidin and erythropoietin level in sickle cell disease. British Journal of Medicine and Medical Research. 2015;8(3):261-5.
  87. Aloh GS, Obeagu EI, Okoroiwu IL, Odo CE, Chibunna OM, Kanu SN, Elemchukwu Q, Okpara KE, Ugwu GU. Antioxidant-Mediated Heinz Bodies Levels of Sickle Erythrocytes under Drug-Induced Oxidative Stress. European Journal of Biomedical and Pharmaceutical sciences. 2015;2(1):502-7.
  88. Umar MI, Aliyu F, Abdullahi MI, Aliyu MN, Isyaku I, Aisha BB, Sadiq RU, Shariff MI, Obeagu EI. Assessment of Factors Precipitating Sickle Cell Crises among Under 5-Years Children Attending Sickle Cell Clinic of Murtala Muhammad Specialist Hospital, Kano. Blood.;11:16.
  89. Obeagu EI, Malot S, Obeagu GU, Ugwu OP. HIV resistance in patients with Sickle Cell Anaemia. Newport International Journal of Scientific and Experimental Sciences (NIJSES). 2023;3(2):56-9.
  90. Obeagu EI, Obeagu GU. Evaluation of Hematological Parameters of Sickle Cell Anemia Patients with Osteomyelitis in A Tertiary Hospital in Enugu, Nigeria. Journal of Clinical and Laboratory Research. 2023;6(1):2768-0487.
  91. Obeagu EI, Bot YS, Opoku D, Obeagu GU, Hassan AO. Sickle Cell Anaemia: Current Burden in Africa. International Journal of Innovative and Applied Research. 2023;11(2):12-4.
  92. Obeagu EI, Obeagu GU. Sickle Cell Anaemia in Pregnancy: A Review. International Research in Medical and Health Sciences. 2023; 6 (2): 10-3.
  93. Obeagu EI, Ogbuabor BN, Ikechukwu OA, Chude CN. Haematological parameters among sickle cell anemia patients’ state and haemoglobin genotype AA individuals at Michael Okpara University of Agriculture, Umudike, Abia State, Nigeria. International Journal of Current Microbiology and Applied Sciences. 2014;3(3):1000-5.
  94. Ifeanyi OE, Nwakaego OB, Angela IO, Nwakaego CC. Haematological parameters among sickle cell anaemia. Int. J. Curr. Microbiol. App. Sci. 2014;3(3):1000-5.
  95. Ezekwe, C. I., Uzomba, C. R., & Ugwu, O. P. C. (2013). The effect of methanol extract of Talinum triangulare (water leaf) on the hematology and some liver parameters of experimental rats. Global Journal of Biotechnology and Biochemistry, 8(2), 51-60.
  96. Nwaka, A. C., Ikechi-Agba, M. C., Okechukwu, P. U., Igwenyi, I. O., Agbafor, K. N., Orji, O. U., & Ezugwu, A. L. (2015). The effects of ethanol extracts of Jatropha curcas on some hematological parameters of chloroform intoxicated rats. American-Eurasian Journal of Scientific Research, 10(1), 45-49.
  97. Enechi, O. C., Okpe, C. C., Ibe, G. N., Omeje, K. O., & Ugwu Okechukwu, P. C. (2016). Effect of Buchholzia coriacea methanol extract on haematological indices and liver function parameters in Plasmodium berghei-infected mice. Global Veterinaria, 16(1), 57-66.
  98. Ezekwe, C. I., Okoro, I. J., Ugwu, P. C., & Ezea, S. C. (2013). The effect of methanol extract of Talinum triangulareon some selected hematological and Kidney parameters of experimental rats. World J Pharm Pharm Sci, 2(6), 4383-4396. Obioma, B. E., Okechukwu, P. U., Emmanuel, I. O., & Ifemeje, J. C. (2014). Antianaemic potential of aqueous leaf extract of Mucuna pruriens on wister albino rats.  J. Curr. Microbiol. App. Sci, 3(1), 707-712.
  99. Chukwuemeka, I., Utuk, G. S., Ugwu Okechukwu, P. C., Ibiam, U. A., Aja, P. M., & Offor, C. E. (2015). The effect of ethanol leaf extract of Jatropha curcas on some haematological parameters of cyclophosphomide induced anaemia in wister albino rats. European Journal of Applied Sciences, 7(1), 17-20.
  • Offor, S. C. E., Ukpabi, E. N., Ogbanshi, M. E., Okechukwu, P. U., & Nwali, B. U. (2014). The effects of ethanol leaf-extract of Anacardium occidentale on haemoglobin and packed cell volume of albino rats. World Journal of Alternative Medicine, 1(1), 05-08.
  • Adonu, C. C., Ugwu, O. P., Bawa, A., Ossai, E. C., & Nwaka, A. C. (2013). Intrinsic blood coagulation studies in patients suffering from both diabetes and hypertension. Int J Pharm Med Bio Sci, 2(2), 36-45.
  • Offor, C. E., Okaka, A. N. C., Ogbugo, S. O., Egwu, C. O., & Ugwu, P. C. Effects of ethanol leaf extract of Pterocarpus santalinoides on haemoglobin, packed cell volume and platelets. IOSR-JNHS 2015; 4: 108, 112.

CITE AS: Emmanuel Ifeanyi Obeagu, Getrude Uzoma Obeagu, Matthew Chibunna Igwe, Esther Ugo Alum and Okechukwu Paul-Chima Ugwu (2023). Men’s Essential roles in the Management of Sickle Cell Anemia.NEWPORT INTERNATIONAL JOURNAL OF SCIENTIFIC AND EXPERIMENTAL SCIENCES 4(2):20-29. https://doi.org/10.59298/NIJSES/2023/10.3.1111

DOWNLOAD PDF